Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.57 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 5/20 | 0.40 |
| ▸ | RAB9A | P51151 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28286129 | 0.77 | AGXT (0.52) | IDO1NPC1RAB9APOLBL3MBTL1 | |
| SCHEMBL21447792 | 0.77 | CYP3A4 (0.44) | RAB9AL3MBTL1ALDH1A1KMT2AMAOA | |
| SCHEMBL27856388 | 0.77 | IDO1 (0.52) | IDO1NPC1RAB9AL3MBTL1KMT2A | |
| SCHEMBL11341386 | 0.76 | IDO1 (0.68) | IDO1RXRARXRBNFE2L2NPC1 | |
| SCHEMBL2293769 | 0.76 | IDO1 (0.68) | IDO1RXRARXRBNFE2L2NPC1 | |
| SCHEMBL873057 | 0.74 | ALDH1A1 (0.60) | IDO1RXRARXRBNFE2L2NPC1 | |
| SCHEMBL764954 | 0.74 | IDO1 (0.65) | IDO1RXRARXRBNFE2L2NPC1 | |
| SCHEMBL7566657 | 0.74 | IDO1 (0.50) | IDO1KDM4EL3MBTL1ALDH1A1KMT2A | |
| SCHEMBL27646961 | 0.73 | IDO1 (0.55) | IDO1NPC1RAB9APOLBMAOB | |
| SCHEMBL260335 | 0.72 | IDO1 (0.63) | IDO1RXRARXRBNFE2L2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| EP-4361342-A1 | PERFUME COMPOSITION | Kao Corporation (JP) | 2024-05-01 | — | — | EP | disclosed |
| EP-3416729-B1 | PRO-FRAGRANCE COMPOSITION | AQDOT LTD (GB) | 2023-09-20 | — | — | EP | disclosed |
| US-11674110-B2 | Compositions containing lauryl methacrylate for malodor reduction and uses thereof | AGILEX FLAVORS AND FRAGRANCES, INC (US) | 2023-06-13 | — | — | US | disclosed |
| EP-3325707-B1 | COMPOSITIONS FOR MALODOR REDUCTION AND USE THEREOF | AGILEX FLAVORS & FRAGRANCES INC (US) | 2021-09-29 | — | — | EP | disclosed |
| US-10695277-B2 | Pro-fragrance composition | AQDOT LIMITED (GB) | 2020-06-30 | — | — | US | disclosed |
| US-20200087596-A1 | COMPOSITIONS FOR MALODOR REDUCTION AND USES THEREOF | Agilex Flavors and Fragrances, Inc. (US) | 2020-03-19 | — | — | US | disclosed |
| CN-105264057-B | Spice composition | 花王株式会社 | 2019-04-05 | — | — | CN | disclosed |
| EP-2496682-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-03-20 | — | — | EP | disclosed |
| US-20190046426-A1 | PRO-FRAGRANCE COMPOSITION | AQDOT LIMITED (GB) | 2019-02-14 | — | — | US | disclosed |
| US-8673272-B2 | Ultraviolet-absorbing compounds | ISP INVESTMENTS INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-8637259-B1 | Methods of identifying modulators of olfactory receptors involved in the perception of sweat carboxylic acids | CHEMCOM S.A. (BE) | 2014-01-28 | — | — | US | disclosed |
| US-20130336910-A1 | OLFACTORY RECEPTORS INVOLVED IN THE PERCEPTION OF SWEAT CARBOXYLIC ACIDS AND THE USE THEREOF | CHEMCOM S.A. (BE) | 2013-12-19 | — | — | US | disclosed |
| US-8357649-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-22 | — | — | US | disclosed |
| US-20110107524-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY | 2011-05-12 | — | — | US | disclosed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | disclosed |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | RESONAC CORPORATION (JP) | 2008-04-10 | — | — | US | disclosed |
| EP-1827370-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | Showa Denko K.K. (JP) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | IDO1 704/4885RXRA 2486/4885RXRB 3101/4885 |
| US-20190046426-A1 | PRO-FRAGRANCE COMPOSITION | COPS5, COPS8, CBR3 | IDO1 2923/4885RXRA 3136/4885RXRB 3365/4885 |
| US-20080085251-A1 | even at a neutral to weakly acidic pH; a lactone or lactam having a mercapto group; with thioglycolic acid, thiolactic acid, cysteine, acetylcysteine, cysteamine, acylcysteamine; | TST, CYSLTR1, CYSLTR2 | IDO1 662/4885RXRA 1417/4885RXRB 1754/4885 |
| US-10695277-B2 | Pro-fragrance composition | COPS5, COPS8, CBR3 | IDO1 2923/4885RXRA 3136/4885RXRB 3365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.